I-3 Treatment of CPT2 deficiency with bezafibrate

por Laforet, P.
Publicado 2011

Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network

por Solé, G., Salort-Campana, E., Pereon, Y., Stojkovic, T., Wahbi, K., Cintas, P., Adams, D., Laforet, P., Tiffreau, V., Desguerre, I., Pisella, L.I., Molon, A., Attarian, S.
Publicado 2020

Scapular dyskinesis in myotonic dystrophy type 1: clinical characteristics and genetic investigations

por Voermans, N. C., van der Bilt, R. C., IJspeert, J., Hogrel, J. Y., Jeanpierre, M., Behin, A., Laforet, P., Stojkovic, T., van Engelen, B. G., Padberg, G. W., Sacconi, S., Lemmers, R. J. L. F., van der Maarel, S. M., Eymard, B., Bassez, G.
Publicado 2019